17 Recruiting Studies Using Sonrotoclax
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Sonrotoclax
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
📍 UCLA Hematologyoncology — Los Angeles, California
Mature B-Cell Malignancies
View Study & Checklist ➔Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
📍 Alaska Oncology and Hematology, Llc — Anchorage, Alaska
CLL
View Study & Checklist ➔A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
📍 City of Hope National Medical Center — Duarte, California
Waldenstrom Macroglobulinemia
View Study & Checklist ➔A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
📍 Cleveland Clinic Florida — Weston, Florida
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia
📍 UT MD Anderson — Houston, Texas
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
📍 Cedars-Sinai Medical Center — Los Angeles, California
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
📍 University of Alabama At Birmingham Hospital — Birmingham, Alabama
Relapsed/Refractory Multiple Myeloma
View Study & Checklist ➔A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
📍 Uci Health Laguna Hills — Laguna Hills, California
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
📍 City of Hope National Medical Center — Duarte, California
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
📍 Mayo Clinic Phoenix — Phoenix, Arizona
B-cell Malignancy
View Study & Checklist ➔Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
📍 City of Hope Medical Center — Duarte, California
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
View Study & Checklist ➔A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
📍 University of Alabama At Birmingham Hospital — Birmingham, Alabama
Mantle Cell Lymphoma
View Study & Checklist ➔Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL
📍 Massachusetts General Hospital — Boston, Massachusetts
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
📍 Moffitt Cancer Center — Tampa, Florida
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
📍 Cross Cancer Institute — Edmonton, Alberta
Mantle Cell Lymphoma
View Study & Checklist ➔BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
📍 Mayo Clinic Arizona — Phoenix, Arizona
Mantle Cell Lymphoma
View Study & Checklist ➔